Back
ACCO Brands 10K Form
Buy
62
ACCO
ACCO Brands
Last Price:
5.89
Seasonality Move:
0.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | ACCO/ACCO Brands Quarterly |
| 2023-11-03 | 10Q | ACCO/ACCO Brands Quarterly |
| 2023-08-09 | 10Q | ACCO/ACCO Brands Quarterly |
| 2023-05-05 | 10Q | ACCO/ACCO Brands Quarterly |
| 2022-11-08 | 10Q | ACCO/ACCO Brands Quarterly |
| 2022-08-09 | 10Q | ACCO/ACCO Brands Quarterly |
Receive ACCO News And Ratings
See the #1 stock for the next 7 days that we like better than ACCO
ACCO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.83B |
|---|---|
| Cash Flow: | $89.2M |
| Price / Cash Flow: | 4.03 |
| Annual Sales: | $6.59 |
| Price / Book: | 0.89 |
Profitability
| EPS (TTM): | -1.89000 |
|---|---|
| Net Income (TTM): | $-181.6M |
| Gross Margin: | $598.3M |
| Return on Equity: | -25.11% |
| Return on Assets: | -7.18% |
ACCO Brands Earnings Forecast
Key ACCO Brands Financial Ratios
- The Gross Profit Margin over the past 30 years for ACCO is 32.64%.
- The Selling, General & Administrative Expenses for ACCO have been equal to 21.57% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -268.81% of Operating Income.
- The Net Earning history of ACCO is -1.19% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 16 years.
ACCO Brands Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Commercial Services & Supplies |
| Sector: | Industrials |
| Current Symbol: | ACCO |
| CUSIP: | 00081T |
| Website: | accobrands.com |
Debt
| Debt-to-Equity Ratio: | 1.48 |
|---|---|
| Current Ratio: | 1.6 |
| Quick Ratio: | 0.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 5.21 |
ACCO Technical Analysis vs Fundamental Analysis
Buy
62
ACCO Brands (ACCO)
is a Buy
Is ACCO Brands a Buy or a Sell?
-
ACCO Brands stock is rated a Buy
The current ACCO Brands [ACCO] share price is $5.89. The Score for ACCO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.